Home
Conditions
Carcinoma, Non-Small-Cell Lung

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,704 public trials 1,044 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Asia PDL1 Study Among NSCLC Patients

NCT03037086

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Research Site Guangzhou, Guangdong, China

Research Site Iizuka-shi, Fukuoka, Japan

Research Site Fukushima, Japan

Research Site Seoul, South Korea

View Trial Details

Completed

A Trial of PTS Via Intratumoral Injection in Patients With Central Air Way NSCLC Severe Obstruction

NCT03448146

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: The First Affiliated Hospital of Guangzhou Medical University Guangzhou, China

View Trial Details

Completed

Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT)

NCT00462995

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Toronto General Hospital Toronto, Ontario, Canada

Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC

NCT00997334

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer

NCT00399789

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: AOI Pharmaceuticals Investigative Site Tucson, Arizona, United States

AOI Pharmaceuticals Investigative Site Pomona, California, United States

AOI Pharmaceuticals Investigative Site Aventura, Florida, United States

AOI Pharmaceuticals Investigative Site Hollywood, Florida, United States

View all 21 locations

View Trial Details

Completed

The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.

NCT03384511

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +44 more
Locations: Jinan, Shandong, China

View Trial Details

Completed

N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus Chemoradiation

NCT02966769

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: Hospital Universitario Quiron Madrid Madrid, Spain

View Trial Details

Completed

Lung Cancer Information Study (LCIS-R01)

NCT01924416

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

EGFR Mutations on ctDNA in Patients With Advanced NSCLC

NCT02623257

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Hangzhou First People's Hospital Hangzhou, Zhejiang, China

View Trial Details

Completed

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy

NCT00738452

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung trial results

Related conditions